Giarola A, Perniola L, Gazzani G, Magni E
Contraception. 1979 Nov;20(5):489-95. doi: 10.1016/0010-7824(79)90054-4.
326 healthy couples were selected to enter the trial of a new intravaginal contraceptive called the TA-RO CAP. The trial lasted three years. Clinical and laboratory examinations were performed periodically to determine the long-term effectiveness, tolerability and acceptance. Statistical evaluation of results was performed by life-table analysis.
326对健康夫妇被选中参与一项名为TA-RO CAP的新型阴道内避孕药的试验。该试验持续了三年。定期进行临床和实验室检查，以确定其长期有效性、耐受性和可接受性。结果通过寿命表分析进行统计学评估。
